Page 13 - Pharma

Private pharmacy chains warming up to unbranded generic medicines

Private chains such as Generico and StayHappi Pharmacy see an opportunity and are aiming to expand rapidly over the coming months

Gujarat sees a surge in small drug firms eyeing regulated export venues

Traditionally, small and medium players had focused on the semi-regulated markets such as Latin America and Africa, among others

Boost in US sales likely to drive re-rating of Indian pharma companies

Price decline has slowed from double digits to lower single digit for Indian pharma companies in US

As generic pharma players lag, investors log into Crams companies

Acceleration in outsourcing trend is expected to help Divi's Labs, Jubilant Life and Syngene post strong revenue growth

Double-digit spend to catapult domestic pharma growth in the next 5 years

This makes India a country with one of the lowest medicine spends

Pharma margins to get rupee boost in Q2, highlights report

This would also safeguard them from margin pressure, said the report

Relax environment norms for export growth, say pharmaceutical firms

Under the current norms, pollution control boards lay down permissible effluent limits while granting approval

Pharma majors plan $2-billion investments to tap new business

India's drug makers spent $1.4 billion in the previous financial on R&D

Pharma industry grows 29% to Rs 2.04 lakh cr in 2015-16

The sector saw FDI equity inflows of $2.25 bn from Apr 2014-Mar 2016, says report

We need a common regulator for pharma sector: Ficci chairman

Pankaj Patel said this would simplify the processes and improve ease of doing business

Indian exports to be hit? Prioritising job creation, Trump targets pharmas

President-elect Donald Trump has announced that creating jobs would be the cornerstone of his presidency and took aim at the pharmaceutical sector vowing to bring the industry back to the US.

Pharma exports from Gujarat grow six-fold in last decade

Gujarat houses nearly 135 licensed medical devices manufacturers in the country

Pharma shares in focus; Lupin, Sun Pharma, Aurobindo up over 3%

The S&P BSE Healthcare index was up 2.4% as compared to 1.5% rise in the S&P BSE Sensex at 02:55 pm

Pharma shares under pressure; Nifty Pharma index down over 3%

Dr Reddys, Sun Pharma, Lupin, Glenmark Pharma and Cadila Healthcare were down between 4% and 5% on the NSE.

Pharma shares surge post Q2 results

Strides Shasun, Jubilant Life Sciences and Sun Pharma Advanced Research were up between 5% and 12%.

SC setback for pharma majors

Total amount these firms owe to government is around Rs 3,500 crore

Three pharma companies to focus on

Aurobindo, Glenmark, Natco see strong domestic and US growth, which should reflect in results

Drug makers go the digital way, arm medical representatives with apps and tablets

Digital platforms are making it simpler for the drug companies to communicate with doctors

PI Industries plans foray into pharma sector

Company has made an investment to the tune of Rs 321.44 crore in FY16 to set up two new state-of-the-art manufacturing facilities

Pharma firms get time to adopt uniform marketing code

The idea behind a uniform code is to ensure fair marketing in the sector. Medical device makers, too, will have to comply